CANY
VRDN icon

Caxton Associates (New York)’s Viridian Therapeutics VRDN Stock Holding History

Caxton Associates (New York)’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,974
Closed -$525K – 635
2022
Q4 		$525K Buy
+17,974
New +$525K 0.04% 210